Literature DB >> 8370147

DNA analysis of distinct populations suggests multiple origins for the mutation causing Huntington disease.

S Andrew1, J Theilmann, E Almqvist, A Norremolle, G Lucotte, M Anvret, S A Sorensen, J C Turpin, M R Hayden.   

Abstract

Results of association studies can be significantly biased if the ancestry of the control population is not similar to that of the affected population. One approach to overcome such a bias is to use distinct populations where controls and affected individuals are likely to be of similar descent. We have examined homogeneous populations of French, Danish and Swedish ancestry for nonrandom allelic association between Huntington disease (HD) and several markers previously shown to be in association with HD. No evidence for nonrandom allelic association between HD and these markers was shown in these populations. The demonstration of association in a United Kingdom (UK) sample of similar size, and lack of significant differences in allele frequencies between the French, Danish, Swedish and UK populations suggested that the absence of association was not predominantly a consequence of allele frequencies or sample size. To investigate further the number of potential HD chromosomes, DNA haplotypes were constructed for the Danish, French, Swedish and UK populations. The minimum of two HD haplotypes observed in each of the French, Danish and Swedish populations, compared to the one haplotype in the UK population of a similar size, is an important factor accounting for the absence of association between HD and the DNA markers in these populations. Furthermore, these data are in favour of multiple independent origins for the mutation causing HD.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8370147     DOI: 10.1111/j.1399-0004.1993.tb03820.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  9 in total

1.  Linkage disequilibrium and extended haplotypes in the HLA-A to D6S105 region: implications for mapping the hemochromatosis gene (HFE).

Authors:  G Gandon; A M Jouanolle; B Chauvel; V Mauvieux; A le Treut; J Feingold; J Y Le Gall; V David; J Yaouanq
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

2.  Geographical distribution of haplotypes in Swedish families with Huntington's disease.

Authors:  E Almqvist; S Andrew; J Theilmann; P Goldberg; J Zeisler; U Drugge; U Grandell; M Tapper-Persson; B Winblad; M Hayden
Journal:  Hum Genet       Date:  1994-08       Impact factor: 4.132

3.  Novel mutations and DNA-based screening in non-Jewish carriers of Tay-Sachs disease.

Authors:  B R Akerman; M R Natowicz; M M Kaback; M Loyer; E Campeau; R A Gravel
Journal:  Am J Hum Genet       Date:  1997-05       Impact factor: 11.025

4.  Huntingtin Haplotypes Provide Prioritized Target Panels for Allele-specific Silencing in Huntington Disease Patients of European Ancestry.

Authors:  Chris Kay; Jennifer A Collins; Niels H Skotte; Amber L Southwell; Simon C Warby; Nicholas S Caron; Crystal N Doty; Betty Nguyen; Annamaria Griguoli; Colin J Ross; Ferdinando Squitieri; Michael R Hayden
Journal:  Mol Ther       Date:  2015-07-23       Impact factor: 11.454

Review 5.  Role of oxidative DNA damage in mitochondrial dysfunction and Huntington's disease pathogenesis.

Authors:  Sylvette Ayala-Peña
Journal:  Free Radic Biol Med       Date:  2013-04-18       Impact factor: 7.376

6.  CAG expansion in the Huntington disease gene is associated with a specific and targetable predisposing haplogroup.

Authors:  Simon C Warby; Alexandre Montpetit; Anna R Hayden; Jeffrey B Carroll; Stefanie L Butland; Henk Visscher; Jennifer A Collins; Alicia Semaka; Thomas J Hudson; Michael R Hayden
Journal:  Am J Hum Genet       Date:  2009-02-26       Impact factor: 11.025

7.  Huntington's Disease: Calcium Dyshomeostasis and Pathology Models.

Authors:  Y A Kolobkova; V A Vigont; A V Shalygin; E V Kaznacheyeva
Journal:  Acta Naturae       Date:  2017 Apr-Jun       Impact factor: 1.845

8.  STIM2 Mediates Excessive Store-Operated Calcium Entry in Patient-Specific iPSC-Derived Neurons Modeling a Juvenile Form of Huntington's Disease.

Authors:  Vladimir A Vigont; Dmitriy A Grekhnev; Olga S Lebedeva; Konstantin O Gusev; Egor A Volovikov; Anton Yu Skopin; Alexandra N Bogomazova; Lilia D Shuvalova; Olga A Zubkova; Ekaterina A Khomyakova; Lyubov N Glushankova; Sergey A Klyushnikov; Sergey N Illarioshkin; Maria A Lagarkova; Elena V Kaznacheyeva
Journal:  Front Cell Dev Biol       Date:  2021-02-02

9.  Systematic metabolic analysis of potential target, therapeutic drug, diagnostic method and animal model applicability in three neurodegenerative diseases.

Authors:  Wen-Xing Li; Gong-Hua Li; Xin Tong; Peng-Peng Yang; Jing-Fei Huang; Lin Xu; Shao-Xing Dai
Journal:  Aging (Albany NY)       Date:  2020-05-27       Impact factor: 5.682

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.